Protocol 64041575RSV2004; A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ

Project: Research project

Project Details

StatusFinished
Effective start/end date11/1/17 → 11/29/19

Funding

  • Janssen Research & Development, LLC